DNL628

· Denali Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNL628, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease [Phase 1]

See pricing